1. Home
  2. CLRB vs WAI Comparison

CLRB vs WAI Comparison

Compare CLRB & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • WAI
  • Stock Information
  • Founded
  • CLRB 2002
  • WAI 2018
  • Country
  • CLRB United States
  • WAI China
  • Employees
  • CLRB N/A
  • WAI N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • WAI
  • Sector
  • CLRB Health Care
  • WAI
  • Exchange
  • CLRB Nasdaq
  • WAI NYSE
  • Market Cap
  • CLRB 76.0M
  • WAI 87.8M
  • IPO Year
  • CLRB N/A
  • WAI 2023
  • Fundamental
  • Price
  • CLRB $1.86
  • WAI $0.48
  • Analyst Decision
  • CLRB Strong Buy
  • WAI
  • Analyst Count
  • CLRB 2
  • WAI 0
  • Target Price
  • CLRB $21.00
  • WAI N/A
  • AVG Volume (30 Days)
  • CLRB 289.0K
  • WAI 67.4K
  • Earning Date
  • CLRB 11-18-2024
  • WAI 11-22-2024
  • Dividend Yield
  • CLRB N/A
  • WAI N/A
  • EPS Growth
  • CLRB N/A
  • WAI N/A
  • EPS
  • CLRB N/A
  • WAI N/A
  • Revenue
  • CLRB N/A
  • WAI $3,989,698.00
  • Revenue This Year
  • CLRB N/A
  • WAI N/A
  • Revenue Next Year
  • CLRB N/A
  • WAI N/A
  • P/E Ratio
  • CLRB N/A
  • WAI N/A
  • Revenue Growth
  • CLRB N/A
  • WAI N/A
  • 52 Week Low
  • CLRB $1.82
  • WAI $0.19
  • 52 Week High
  • CLRB $4.45
  • WAI $2.14
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 30.70
  • WAI N/A
  • Support Level
  • CLRB $1.97
  • WAI N/A
  • Resistance Level
  • CLRB $2.18
  • WAI N/A
  • Average True Range (ATR)
  • CLRB 0.10
  • WAI 0.00
  • MACD
  • CLRB -0.01
  • WAI 0.00
  • Stochastic Oscillator
  • CLRB 8.11
  • WAI 0.00

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: